Stocks Health care INNPF
OTC · Health careINNOCAN PHARMA Corp (INNPF)
We have not processed filings for INNOCAN PHARMA Corp yet. This page fills in on its own once we have read them.
What INNOCAN PHARMA Corp does
INNOCAN PHARMA Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker INNPF.
Earnings: every quarter and the next report date
Latest SEC filings
What INNOCAN PHARMA Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- April 3, 2026
- March 16, 2026
- February 23, 2026
- January 7, 2026
- January 6, 2026
- December 22, 2025Form 8-A12B/A filing 8-A12B/A
- December 19, 2025Form 8-A12B/A filing 8-A12B/A
- December 16, 2025Form 8-A12B/A filing 8-A12B/A
- December 10, 2025
- November 10, 2025Form DEL AM filing DEL AM
Questions about INNPF
What does INNOCAN PHARMA Corp do?
INNOCAN PHARMA Corp is a company in the Health care sector, listed on OTC as INNPF. Its shares trade on OTC under the ticker INNPF.
When did INNOCAN PHARMA Corp last report?
Its newest filing of any kind is the iPO registration (foreign issuer) (amended) from April 3, 2026.
Similar companies
Compare INNPF with
Compare INNPF with any company
Follow INNPF
Get an email when INNOCAN PHARMA Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values INNOCAN PHARMA Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.